Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
Year: 2017
Type: review
Abstract: Esophageal squamous cell carcinoma (ESCC) is a common malignancy without effective therapy. The exomes of more than 600 ESCCs have been sequenced in the past 4 years, and numerous key aberrations have been identified. Recently, researchers reported both inter- and intratumor heterogeneity. Although these are interesting observations, their clinical implications are unclear due to the limited number of samples profiled. Epigenomic alterations, such as changes in DNA methylation, histone acetylation, and RNA editing, also have been observed in ESCCs. However, it is not clear what proportion of ESCC cells carry these epigenomic aberrations or how they contribute to tumor development. We review the genomic and epigenomic characteristics of ESCCs, with a focus on emerging themes. We discuss their clinical implications and future research directions.
Source: Gastroenterology
Institutions: Cedars-Sinai Medical Center, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Molecular Oncology, National University of Singapore, National University Cancer Institute, Singapore, National University Hospital, Cancer Science Institute of Singapore
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,180
Funders: Tower Cancer Research Foundation, National Research Foundation Singapore, National Natural Science Foundation of China, National Institutes of Health, National Medical Research Council, National Center for Advancing Translational Sciences, Clinical and Translational Science Institute, University of California, Los Angeles
OpenAlex ID: W2740910083
